China - Import of Heparin for Therapeutic Use
Since 2014, China Import of Heparin for Therapeutic Use jumped by 92.5% year on year. In 2019, the country was number 14 comparing other countries in Import of Heparin for Therapeutic Use at $51,259,004.53. China is overtaken by South Korea, which was ranked number 13 with $66,154,928.55 and is followed by United Kingdom at $45,170,786.46. France ranked the highest with $960,128,653.6 in 2019, that is a fall of 6.6% versus 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize recorded the best 5 years average growth at +183.7% per year, while Mauritania recorded the worst performance at -81.7% per year.
| Date | US Dollars |
|---|---|
| 2019 | 51,259,004.53 |
| 2018 | 55,636,136.00 |
| 2017 | 26,082,450.00 |
| 2016 | 26,371,640.00 |
| 2015 | 14,269,354.00 |
Download all data from 1992 to 2019
How does China rank in Import of Heparin for Therapeutic Use?
| # | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data | |
| 2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data | |
| 13 |
#13
South Korea
|
66,154,928.55 | 2019 | +4.3 % | +5.8 % | View data | |
| 14 |
#14
China
|
51,259,004.53 | 2019 | -7.9 % | +92.5 % | View data | |
| 15 |
#15
United Kingdom
|
45,170,786.46 | 2019 | -1.9 % | -6.9 % | View data | |